Clinical Trial Update: Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and tolerability of a 15-minute intravenous infusion of levetiracetam in patients with partial onset seizures (epilepsy). The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED